TOPIC
Novavax
Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy
Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals